Search Results - Townsend, Julia Alma

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

    Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease by Ma, Chunlong, Sacco, Michael Dominic, Hurst, Brett, Townsend, Julia Alma, Hu, Yanmei, Szeto, Tommy, Zhang, Xiujun, Tarbet, Bart, Marty, Michael Thomas, Chen, Yu, Wang, Jun

    Published in Cell research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Expedited Approach toward the Rational Design of Noncovalent SARS-CoV‑2 Main Protease Inhibitors

    Expedited Approach toward the Rational Design of Noncovalent SARS-CoV‑2 Main Protease Inhibitors by Kitamura, Naoya, Sacco, Michael Dominic, Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Meng, Xiangzhi, Zhang, Fushun, Zhang, Xiujun, Ba, Mandy, Szeto, Tommy, Kukuljac, Adis, Marty, Michael Thomas, Schultz, David, Cherry, Sara, Xiang, Yan, Chen, Yu, Wang, Jun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors

    Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors by Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Lagarias, Panagiotis I, Marty, Michael Thomas, Kolocouris, Antonios, Wang, Jun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Discovery of SARS-CoV‑2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

    Discovery of SARS-CoV‑2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay by Ma, Chunlong, Sacco, Michael Dominic, Xia, Zilei, Lambrinidis, George, Townsend, Julia Alma, Hu, Yanmei, Meng, Xiangzhi, Szeto, Tommy, Ba, Mandy, Zhang, Xiujun, Gongora, Maura, Zhang, Fushun, Marty, Michael Thomas, Xiang, Yan, Kolocouris, Antonios, Chen, Yu, Wang, Jun

    Published in ACS central science
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV‑2 Main Protease Inhibitors with High Target Specificity

    Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV‑2 Main Protease Inhibitors with High Target Specificity by Ma, Chunlong, Xia, Zilei, Sacco, Michael Dominic, Hu, Yanmei, Townsend, Julia Alma, Meng, Xiangzhi, Choza, Juliana, Tan, Haozhou, Jang, Janice, Gongora, Maura V, Zhang, Xiujun, Zhang, Fushun, Xiang, Yan, Marty, Michael Thomas, Chen, Yu, Wang, Jun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L

    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L by Sacco, Michael Dominic, Ma, Chunlong, Lagarias, Panagiotis, Gao, Ang, Townsend, Julia Alma, Meng, Xiangzhi, Dube, Peter, Zhang, Xiujun, Hu, Yanmei, Kitamura, Naoya, Hurst, Brett, Tarbet, Bart, Marty, Michael Thomas, Kolocouris, Antonios, Xiang, Yan, Chen, Yu, Wang, Jun

    Published in Science advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L

    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L by Lagarias, Panagiotis, Gao, Ang, Townsend, Julia Alma, Meng, Xiangzhi, Dube, Peter, Zhang, Xiujun, Hu, Yanmei, Kitamura, Naoya, Kolocouris, Antonios, Yan, Xiang

    Published in Science Advances
    Request full text
    Article
    Save to List
    Saved in:
  8. 8
    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibititors against Mpro and cathepsin L

    Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibititors against Mpro and cathepsin L by Sacco, Michael Dominic, Ma, Chunlong, Lagarias, Panagiotis, Gao, Ang, Townsend, Julia Alma, Meng, Xiangzhi, Dube, Peter, Zhang, Xiujun, Hu, Yanmei, Kitamura, Naoya, Hurst, Brett, Tarbet, Bart, Marty, Michael Thomas, Kolocouris, Antonios, Xiang, Yan, Chen, Yu, Wang, Jun

    Published in Science advances
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors

    Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors by Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Lagarias, Panagiotis I, Marty, Michael Thomas, Kolocouris, Antonios, Wang, Jun

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:
  10. 10
    Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay

    Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay by Xia, Zilei, Sacco, Michael Dominic, Ma, Chunlong, Townsend, Julia Alma, Kitamura, Naoya, Hu, Yanmei, Ba, Mandy, Szeto, Tommy, Zhang, Xiujun, Meng, Xiangzhi, Zhang, Fushun, Yan, Xiang, Marty, Michael Thomas, Chen, Yu, Wang, Jun

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:
  11. 11
    An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity

    An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity by Kitamura, Naoya, Sacco, Michael Dominic, Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Meng, Xiangzhi, Zhang, Fushun, Zhang, Xiujun, Kukuljac, Adis, Marty, Michael Thomas, Schultz, David, Cherry, Sara, Yan, Xiang, Chen, Yu, Wang, Jun

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:

Search Tools: